EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001193125-26-207537

Filing information

CIK: 0001314102
Report date: 2026-05-06
Filing date: 2026-05-06
Form: 8-K
Primary document: eypt-20260506.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.